Northwestern Mutual Wealth Management
AMRX icon

Northwestern Mutual Wealth Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-155
Closed -$1.55K – 4018
2025
Q3 		$1.55K Buy
+155
New +$1.39K ﹤0.01% 3452
2022
Q3 		– Sell
-275
Closed -$1K – 3096
2022
Q2 		$1K Buy
+275
New +$996 ﹤0.01% 2989
2021
Q3 		– Sell
-1
Closed – – 2995
2021
Q2 		$0 Buy
+1
New +$6 ﹤0.01% 2980
2018
Q3 		– Sell
-452
Closed -$7K – 2454
2018
Q2 		$7K Buy
+452
New +$7.93K ﹤0.01% 1917

Other funds holding AMRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Northwestern Mutual Wealth Management's AMRX Position: Q4 2025 in Review

Northwestern Mutual Wealth Management sold out of Amneal Pharmaceuticals (AMRX) in Q4 2025, closing a stake of 155 shares — an estimated $1.55K sold.

Northwestern Mutual Wealth Management first reported a position in AMRX in Q2 2018 and held it in 4 quarters. The position peaked at $7K in Q2 2018. 277 funds tracked by Wall St. Rank hold AMRX as of Q4 2025.

  • Northwestern Mutual Wealth Management reported no remaining Amneal Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 155 Amneal Pharmaceuticals shares in Q4 2025, an estimated $1.55K.
  • Northwestern Mutual Wealth Management first reported a position in Amneal Pharmaceuticals in Q2 2018 and held it in 4 quarters.
  • Northwestern Mutual Wealth Management's Amneal Pharmaceuticals position peaked at $7K in Q2 2018.
  • 277 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2025.

Based on Northwestern Mutual Wealth Management's 13F filing for Q4 2025, filed 5 Feb 2026.